Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Compounding pharmacies are facilities that are able to make customized medications. This could be to alter a drug's dosage or composition for medical purposes. Many patients have benefitted from drug ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

Compounding is the act of mixing, combining, or altering ingredients to tailor a medication to an individual’s needs. Generally, compounding a medication is done by a licensed pharmacist, a licensed ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

Eli Lilly warns compounded tirzepatide mixed with B12 may contain impurities and safety risks as FDA tightens GLP-1 rules—get the latest updates now.

Compounded medications are custom drugs, which the FDA does not regulate like regular prescription drugs. You may need ...

The health care industry has never encountered anything quite like Ozempic before. First approved to treat Type 2 diabetes, this drug and others like it—known as GLP-1 agonists—hit blockbuster status ...

A Kentucky lawmaker has filed a new bill that would strengthen oversight of compounded drugs, including weight loss medication.